Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Gennarina Arabia 3"'
Autor:
Salvatore Nigro 1, Maria Giovanna Bianco 2, Gennarina Arabia 3, Maurizio Morelli 3, Rita Nisticò 4, Fabiana Novellino 4, Maria Salsone 4, Antonio Augimeri 5, Aldo Quattrone 3, 4, 6
Publikováno v:
Human brain mapping
40 (2019): 1729–1737. doi:10.1002/hbm.24484.
info:cnr-pdr/source/autori:Salvatore Nigro 1, Maria Giovanna Bianco 2, Gennarina Arabia 3, Maurizio Morelli 3, Rita Nisticò 4, Fabiana Novellino 4, Maria Salsone 4, Antonio Augimeri 5, Aldo Quattrone 3,4,6/titolo:Track density imaging in progressive supranuclear palsy: A pilot study./doi:10.1002%2Fhbm.24484./rivista:Human brain mapping (Print)/anno:2019/pagina_da:1729/pagina_a:1737/intervallo_pagine:1729–1737/volume:40
40 (2019): 1729–1737. doi:10.1002/hbm.24484.
info:cnr-pdr/source/autori:Salvatore Nigro 1, Maria Giovanna Bianco 2, Gennarina Arabia 3, Maurizio Morelli 3, Rita Nisticò 4, Fabiana Novellino 4, Maria Salsone 4, Antonio Augimeri 5, Aldo Quattrone 3,4,6/titolo:Track density imaging in progressive supranuclear palsy: A pilot study./doi:10.1002%2Fhbm.24484./rivista:Human brain mapping (Print)/anno:2019/pagina_da:1729/pagina_a:1737/intervallo_pagine:1729–1737/volume:40
Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by white matter (WM) changes in different supra- and infratentorial brain structures. We used track density imaging (TDI) to characterize WM microstructural alteration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::4be7dd47da23bfdef0ced4a0392a4dc2
https://publications.cnr.it/doc/394443
https://publications.cnr.it/doc/394443
Autor:
Alessandra Nicoletti 1, Giovanni Mostile 1, Giuseppe Nicoletti 2, Gennarina Arabia 3, Giovanni Iliceto 4, Paolo Lamberti 4, Roberto Marconi 5, Letterio Morgante 6, Paolo Barone 7, Aldo Quattrone 2, 3, Mario Zappia 1
Publikováno v:
Journal of neurology
263 (2016): 888–894. doi:10.1007/s00415-016-8075-6
info:cnr-pdr/source/autori:Alessandra Nicoletti 1, Giovanni Mostile 1, Giuseppe Nicoletti 2, Gennarina Arabia 3, Giovanni Iliceto 4, Paolo Lamberti 4, Roberto Marconi 5, Letterio Morgante 6, Paolo Barone 7, Aldo Quattrone 2,3, Mario Zappia 1/titolo:Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease./doi:10.1007%2Fs00415-016-8075-6/rivista:Journal of neurology (Print)/anno:2016/pagina_da:888/pagina_a:894/intervallo_pagine:888–894/volume:263
263 (2016): 888–894. doi:10.1007/s00415-016-8075-6
info:cnr-pdr/source/autori:Alessandra Nicoletti 1, Giovanni Mostile 1, Giuseppe Nicoletti 2, Gennarina Arabia 3, Giovanni Iliceto 4, Paolo Lamberti 4, Roberto Marconi 5, Letterio Morgante 6, Paolo Barone 7, Aldo Quattrone 2,3, Mario Zappia 1/titolo:Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease./doi:10.1007%2Fs00415-016-8075-6/rivista:Journal of neurology (Print)/anno:2016/pagina_da:888/pagina_a:894/intervallo_pagine:888–894/volume:263
It is unclear whether patients with different clinical phenotypes of Parkinson's disease (PD) differ in their risk of developing levodopa-induced dyskinesia. We evaluated the possible association between clinical phenotypes and risk of levodopa-induc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be78b889599d378033272825fcf7c61a
https://doi.org/10.1007/s00415-016-8075-6
https://doi.org/10.1007/s00415-016-8075-6
